Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPINIROLE vs ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROPINIROLE vs ROSUVASTATIN: Safety Overview

Metric ROPINIROLE ROSUVASTATIN
Total FAERS Reports 4,239 36,332
Deaths Reported 310 1,536
Death Rate 7.3% 4.2%
Hospitalizations 1,192 11,195
Average Patient Age 65.5 yrs 66.1 yrs
% Female Patients 56.7% 54.9%
FDA Approval Date Apr 10, 2009 Apr 1, 2020
Manufacturer SOLCO HEALTHCARE US, LLC Umedica Laboratories USA Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription